Journal article
Intravenous Immunoglobulin Does Not Improve Outcome in Toxic Epidermal Necrolysis
Abstract
Intravenous Immunoglobulin (IVIG) has been proposed as a beneficial therapy for toxic epidermal necrolysis (TEN). However, this has been based on a limited amount of Class 5 evidence. To compare outcomes in TEN patients treated in our burn unit since 1999, when we began to use IVIG (IG group), with TEN patients treated between 1995 and 1999 who did not receive IVIG (control group). Retrospective cohort review of the records of all TEN patients …
Authors
Shortt R; Gomez M; Mittman N; Cartotto R
Journal
Journal of Burn Care & Research, Vol. 25, No. 3, pp. 246–255
Publisher
Oxford University Press (OUP)
Publication Date
May 1, 2004
DOI
10.1097/01.bcr.0000124746.33279.86
ISSN
1559-047X